Welcome
Support Centre
22 November 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A Prospective descriptive Pilot Trial to investigate tracheal reflux in the early post-operative period in patients undergoing thoracotomy for lung resection.
ISRCTN ISRCTN88216651
ClinicalTrials.gov identifier
Public title A Prospective descriptive Pilot Trial to investigate tracheal reflux in the early post-operative period in patients undergoing thoracotomy for lung resection.
Scientific title
Acronym N/A
Serial number at source N0054128023
Study hypothesis A Randomised Controlled Trial to investigate tracheal reflux in the early postoperative period. Can acid reflux be reduced by the oral administration of a Proton Pump Inhibitor?
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Surgery: Thoracotomy
Participants - inclusion criteria 50 patients undergoing Thoracotomy.
Patients who have thyroid goitre or pathology making thyrocricoid puncture difficult will be excluded. Patients with a history of gastro-oesophageal reflux disease (GORD), Hiatus hernia or currently taking proton pump inhibitor (PPI)/antacid will also be excluded.
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/06/2003
Anticipated end date 31/12/2003
Status of trial Completed
Patient information material
Target number of participants 50
Interventions A Prospective Randomised Double Blind Controlled Trial to investigate tracheal reflux in the early post-operative period. Consenting patients who are presenting for Thoracotomy for Lung resection under the care of two Thoracic surgeons. Patients after completion of surgery but prior to reversal of general anaesthetic, will have a 1.5 mm antimony pH probe inserted percutaneously under brochoscopic control into the trachea via the cricothyroid membrane. The device will then record and store pH every 5 seconds for the first 48 hour post-operatively, The data will be analysed for number and duration of aspiration episodes.
Primary outcome measure(s) Study end points will be:
1. The number of episodes per hour as defined by a reversible decrease in pH to less than 6.5 and lasting at least 1 min
2. The fractional (%) time the pH is less than 6.5
3. The number of aspiration episodes lasting more than 5 min
Secondary outcome measure(s) Not provided at time of registration
Sources of funding The Cardiothoracic Centre Liverpool NHS Trust
Trial website
Publications
Contact name Dr  E  McCarron
  Address Department of Cardiac Surgery
The Cardiothoracic Centre
Liverpool NHS Trust
Thomas Drive
  City/town Liverpool
  Zip/Postcode L14 3PE
  Country United Kingdom
  Tel +44 (0)151 228 1616
  Fax +44 (0)151 228 8573
  Email
Sponsor Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2004
Last edited 22/12/2005
Date ISRCTN assigned 30/09/2004
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central